[1]
M. R. Jones, MD, A. D. Kaye, MD, PhD, A. J. Kaye, BA, and R. D. Urman, MD, MBA, “The emerging therapeutic roles of κ-opioid agonists”, J of Opioid Management, vol. 12, no. 2, pp. 101–107, Mar. 2016.